Intratumoral injection of STAT3 inhibitors also does not impede tumor growth, but it is surprising that the combination of sialiadase and STAT3 inhibitor JSI-124 can produce significant anti-tumor effects, which is related to the consumption of MDSCs at the tumor site (55). The gene discussed is STAT3; the disease is neoplasm.